|
|
||||||||
1 Department of Medicine, University of Florida College of Medicine; and 2 Research Service, Malcom Randall Department of Veterans Affairs Medical Center, Gainesville, Florida 32608-1197
Signaling events
involving angiotensin IV (ANG IV)-mediated pulmonary artery endothelial
cell (PAEC) proliferation were examined. ANG IV significantly increased
upstream phosphatidylinositide (PI) 3-kinase (PI3K), PI-dependent
kinase-1 (PDK-1), extracellular signal-related kinases (ERK1/2), and
protein kinase B-
/Akt (PKB-
) activities, as well as downstream
p70 ribosomal S6 kinase (p70S6K) activities and/or phosphorylation of
these proteins. ANG IV also significantly increased
5-bromo-2'-deoxy-uridine incorporation into newly synthesized DNA in a
concentration- and time-dependent manner. Pretreatment of cells with
wortmannin and LY-294002, inhibitors of PI3K, or rapamycin, an
inhibitor of the mammalian target of rapamycin kinase and p70S6K,
diminished the ANG IV-mediated activation of PDK-1 and PKB-
as well
as phosphorylation of p70S6K. Although an inhibitor of
mitogen-activated protein kinase kinase, PD-98059, but not rapamycin,
blocked ANG IV-induced phosphorylation of ERK1/2, both PD-98059 and
rapamycin independently caused partial reduction in ANG IV-mediated
cell proliferation. However, simultaneous treatment with PD-98059 and
rapamycin resulted in total inhibition of ANG IV-induced cell
proliferation. These results demonstrate that ANG IV-induced DNA
synthesis is regulated in a coordinated fashion involving multiple
signaling modules in PAEC.
p70 S6 kinase; protein kinase B; phosphatidylinositol 3-kinase
This article has been cited by other articles:
![]() |
A. Ogawa, A. L. Firth, W. Yao, M. M. Madani, K. M. Kerr, W. R. Auger, S. W. Jamieson, P. A. Thistlethwaite, and J. X.-J. Yuan Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L666 - L676. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. C. Li, D. J. Campbell, M. Ohishi, S. Yuan, and J. L. Zhuo AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1024 - F1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Esteban, M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, O. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, and M. Ruiz-Ortega Angiotensin IV Activates the Nuclear Transcription Factor-{kappa}B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells Circ. Res., May 13, 2005; 96(9): 965 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Watanabe, T. A. Barker, and B. C. Berk Angiotensin II and the Endothelium: Diverse Signals and Effects Hypertension, February 1, 2005; 45(2): 163 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lochard, G. Thibault, D. W. Silversides, R. M. Touyz, and T. L. Reudelhuber Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist Circ. Res., June 11, 2004; 94(11): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |